These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1320731)

  • 1. Myasthenia gravis and pipecuronium--report of two cases.
    Naguib M; Sari-Kouzel A; Ashour M; Seraj M; Messahel F
    Middle East J Anaesthesiol; 1992 Feb; 11(4):381-90. PubMed ID: 1320731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxide-fentanyl anaesthesia in adult surgical patients.
    Sanfilippo M; Fierro G; Vilardi V; Rosa G; De Gregorio AL; Gasparetto A
    Eur J Anaesthesiol; 1992 Jan; 9(1):49-53. PubMed ID: 1310464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intubating conditions after pipecuronium bromide: the influence of dose and time.
    Azad SS; Larijani GE; Bartkowski R; Seltzer JL; Weinberger M; Marr A; Goldberg ME
    J Clin Anesth; 1991; 3(3):202-6. PubMed ID: 1652264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children].
    Praefort L
    Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.
    Abdulatif M; Naguib M
    Can J Anaesth; 1991 Mar; 38(2):159-63. PubMed ID: 1850665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia.
    Azad SS; Larijani GE; Goldberg ME; Beach CA; Marr AT; Seltzer JL
    J Clin Pharmacol; 1989 Jul; 29(7):657-9. PubMed ID: 2547848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children.
    Pittet JF; Tassonyi E; Morel DR; Gemperle G; Richter M; Rouge JC
    Anesthesiology; 1989 Aug; 71(2):210-3. PubMed ID: 2547325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular effect of pipecuronium bromide in infants and children during nitrous oxide-alfentanil anesthesia.
    Pittet JF; Tassonyi E; Morel DR; Gemperle G; Rouge JC
    Anesthesiology; 1990 Mar; 72(3):432-5. PubMed ID: 2155549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting neuromuscular blockade from pipecuronium.
    Caballero PA; Johnstone RE
    Anesthesiology; 1992 Jan; 76(1):154-5. PubMed ID: 1309627
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pipecuronium bromide.
    Benad G; Hofmockel R
    Br J Hosp Med; 1991 May; 45(5):308. PubMed ID: 1648418
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the neuromuscular blocking effect of Arduan.
    Tassonyi E
    Ther Hung; 1983; 31(1):13-7. PubMed ID: 6100820
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium.
    Dubois MY; Fleming NW; Lea DE
    Anesth Analg; 1991 Mar; 72(3):364-8. PubMed ID: 1847278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arduan muscle relaxation prolonged with norcuron.
    Fister T
    Ther Hung; 1991; 39(3):125-7. PubMed ID: 1687841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.